These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26732544)

  • 1. B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation.
    Michel L; Touil H; Pikor NB; Gommerman JL; Prat A; Bar-Or A
    Front Immunol; 2015; 6():636. PubMed ID: 26732544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
    Touil H; Kobert A; Lebeurrier N; Rieger A; Saikali P; Lambert C; Fawaz L; Moore CS; Prat A; Gommerman J; Antel JP; Itoyama Y; Nakashima I; Bar-Or A;
    J Neuroinflammation; 2018 Apr; 15(1):114. PubMed ID: 29673365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ins and Outs of B Cells in Multiple Sclerosis.
    Blauth K; Owens GP; Bennett JL
    Front Immunol; 2015; 6():565. PubMed ID: 26594215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaching Brain Barriers: B Cell Migration in Multiple Sclerosis.
    Rodriguez-Mogeda C; Rodríguez-Lorenzo S; Attia J; van Horssen J; Witte ME; de Vries HE
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression.
    Fraussen J; de Bock L; Somers V
    Autoimmun Rev; 2016 Sep; 15(9):896-9. PubMed ID: 27396817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the role of B cells in the cortical pathology of Multiple sclerosis: evidence from animal models and patients.
    Silva BA; Miglietta E; Ferrari CC
    Mult Scler Relat Disord; 2021 May; 50():102845. PubMed ID: 33636613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell depletion therapy for multiple sclerosis.
    Miyazaki Y; Niino M
    Immunol Med; 2022 Jun; 45(2):54-62. PubMed ID: 34289331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.
    Atkinson JR; Bergmann CC
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chronically inflamed central nervous system provides niches for long-lived plasma cells.
    Pollok K; Mothes R; Ulbricht C; Liebheit A; Gerken JD; Uhlmann S; Paul F; Niesner R; Radbruch H; Hauser AE
    Acta Neuropathol Commun; 2017 Nov; 5(1):88. PubMed ID: 29178933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins.
    Willis SN; Stathopoulos P; Chastre A; Compton SD; Hafler DA; O'Connor KC
    Front Immunol; 2015; 6():600. PubMed ID: 26648933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.
    Claes N; Fraussen J; Stinissen P; Hupperts R; Somers V
    Front Immunol; 2015; 6():642. PubMed ID: 26734009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.
    Church ME; Ceja G; McGeehan M; Miller MC; Farias P; Sánchez MD; Swain GP; Assenmacher CA; Stopa EG; Vite CH; Bar-Or A; Alvarez JI
    J Immunol; 2021 Jul; 207(1):44-54. PubMed ID: 34162727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningeal and choroid plexus cells--novel drug targets for CNS disorders.
    Dragunow M
    Brain Res; 2013 Mar; 1501():32-55. PubMed ID: 23328079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
    Komori M; Lin YC; Cortese I; Blake A; Ohayon J; Cherup J; Maric D; Kosa P; Wu T; Bielekova B
    Ann Clin Transl Neurol; 2016 Mar; 3(3):166-79. PubMed ID: 27042677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of B cells in multiple sclerosis: more than antibodies.
    Funaro M; Messina M; Shabbir M; Wright P; Najjar S; Tabansky I; Stern JN
    Discov Med; 2016 Nov; 22(122):251-255. PubMed ID: 28009967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.
    Pedemonte E; Mancardi G; Giunti D; Corcione A; Benvenuto F; Pistoia V; Uccelli A
    Pharmacol Ther; 2006 Sep; 111(3):555-66. PubMed ID: 16442633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in meningeal inflammation correspond to clinical exacerbations in a murine model of relapsing-remitting multiple sclerosis.
    Walker-Caulfield ME; Hatfield JK; Brown MA
    J Neuroimmunol; 2015 Jan; 278():112-22. PubMed ID: 25595260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.